Women of childbearing age are, compared to men, underrepresented in MS therapy. This was shown by a recent study. There is a gender gap in the use of immunomodulatory therapies (DMT). However, this does not
Continue reading I have posted several articles on the topic of pregnancy and MS, to which I would also like to refer here (e.g. Pregnancy and breastfeeding). There were now some interesting news on this topic at
Continue reading
Cladribine is a prodrug, which is activated after being inserted into body cells and incorporated into the DNA of cells as a so-called nucleoside analogue. This integration leads to programmed cell death.
Continue reading
In view of practically relevant results from this year’s ECTRIMS meeting, I would like to emphasize studies on pregnancy and breastfeeding. B-cell-depleting therapies such as ocrelizumab and ofatumumab are often used in women of childbearing
Continue reading Interferons are the “original substances” for the treatment of Multiple Sclerosis. In 1993, Interferon-beta 1b (Betaferon®) from Schering (now part of the Bayer Group) was the first modern immunotherapy to be approved for MS. This
Continue reading Dimethyl fumarate is marketed in Germany under the trade name Tecfidera® by the company Biogen, but is now also available generically (see MS-Docblog). Dimethyl fumarate is approved for the treatment of relapsing multiple sclerosis in
Continue reading
In addition to the effects of a substance, its side effects play an important role not only in the decision for therapy, but also in the practical application of MS therapy. This article is about
Continue reading
Although the availability of information is currently excellent, I find that there is still a great deal of uncertainty among MS patients, whether with immunotherapy or without, regarding vaccination against SARS-CoV2. Therefore, once again, a
Continue reading
In late September 2019, the Committee for Medicinal Products for Human Use of the European Medicines Agency recommended a change in the authorization of Interferon-beta therapy during pregnancy and lactation. Although this is actually very
Continue readingOn 09.01.2019, I posted an article about MS medication during pregnancy online. In response, a comment was made by Faxe saying “Good to know, but what about the gentlemen?” He’s completely right – the advice
Continue reading
Unsere Website verwendet Cookies und sammelt dabei Informationen über Ihren Besuch, um unsere Website zu verbessern (durch Analyse), Ihnen Social Media-Inhalte und relevante Werbung anzuzeigen. Weitere Informationen finden Sie auf unserer Seite . Sie können zustimmen, indem Sie auf die Schaltfläche "Akzeptieren" klicken.
Cookie-Einstellungen
Unten können Sie auswählen, welche Art von Cookies Sie auf dieser Website zulassen. Klicken Sie auf die Schaltfläche "Cookie-Einstellungen speichern", um Ihre Auswahl zu übernehmen.
Dieser Inhalt ist gesperrt. Akzeptieren Sie Cookies in der Kategorie '%CC%', um diesen Inhalt anzuzeigen.
